Repros Therapeutics Inc Stock

Stocks

18-01-26	Repros Announces Negative Opinion From the EMA for Enclomiphene	GL
17-12-15	Repros Therapeutics Inc.® Receives Feedback Following an Oral Explanation with the European Medicines Agency	GL
17-12-12	REPROS THERAPEUTICS INC. Rigrodsky & Long, P.A. Announces Investigation of Buyout	BU
17-12-12	Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of Repros Therapeutics Inc. to Allergan plc is Fair to Shareholders	BU
17-12-12	Repros Therapeutics Inc.® Announces Acquisition by Allergan plc	GL

15-04-02	Apple : Les valeurs à suivre sur les marchés américains
15-04-02	USA-Les valeurs à suivre à Wall Street

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
REPROS THERAPEUTICS INC	-.--%	+0.74%	-	-	0
LONZA GROUP AG	-1.40%	+0.12%	-14.73%	-12.58%	43.68B
REVOLUTION MEDICINES, INC.	+3.50%	-4.15%	+265.85%	+484.30%	30.65B
IQVIA HOLDINGS INC.	-0.61%	-3.11%	+14.00%	-12.36%	30.4B
BEONE MEDICINES AG	-1.27%	-7.02%	-0.82%	+20.47%	29.31B
CELLTRION, INC.	-0.66%	-5.84%	+7.59%	+12.76%	24.2B
MEDPACE HOLDINGS, INC.	+2.01%	+3.57%	+57.15%	+128.55%	13.3B
EUROFINS SCIENTIFIC SE	-1.65%	-1.08%	+7.92%	+7.56%	13.21B
ASCENDIS PHARMA A/S	+2.77%	-1.48%	-	-	13.03B
IONIS PHARMACEUTICALS, INC.	+0.68%	-1.74%	+103.98%	+81.60%	12.12B
Average	+0.34%	-1.64%	+55.12%	+88.79%	23.32B
Weighted average by Cap.	+0.11%	-1.65%	+51.89%	+89.54%